Provided by Tiger Trade Technology Pte. Ltd.

Everus Construction Group, Inc.

113.70
-1.4300-1.24%
Post-market: 113.700.00000.00%16:27 EDT
Volume:600.97K
Turnover:68.06M
Market Cap:5.80B
PE:22.83
High:115.50
Open:113.61
Low:111.25
Close:115.13
52wk High:171.58
52wk Low:73.00
Shares:51.01M
Float Shares:50.85M
Volume Ratio:1.29
T/O Rate:1.18%
Dividend:- -
Dividend Rate:- -
EPS(TTM):4.98
EPS(LYR):3.95
ROE:39.52%
ROA:11.68%
PB:7.50
PE(LYR):28.78

Loading ...

Everus Construction Group Inc - Buys Se&M for $158 Mln Funded by Cash on Hand

THOMSON REUTERS
·
Apr 02

Everus Construction Group Inc - Deal Terms Allow Potential Earnout up to 8% of Purchase Price

THOMSON REUTERS
·
Apr 02

Everus Acquires Se&M, Leading Contractor in Southeast Region

THOMSON REUTERS
·
Apr 02

AI/ML Innovations Strikes ECG Tech Reseller Deal in European Digital Cardiology

TIPRANKS
·
Apr 01

Milestone Pharmaceuticals Announces that CARDAMYST™ (etripamil) Nasal Spray is Available on Express Scripts Commercial National Formularies

GlobeNewswire
·
Mar 31

Data presented at ACC.26 further demonstrate the benefits of iRhythm’s Zio® ambulatory ECG portfolio across multiple patient populations as company launches new digital education platform

GlobeNewswire
·
Mar 30

Everus Construction Group announces annual stockholder meeting; FY2025 revenue rises to $3.8 billion

Reuters
·
Mar 27

HeartBeam (NASDAQ: BEAT) Partners with Mount Sinai to Accelerate AI-ECG Development and Validation

TIPRANKS
·
Mar 26

HeartSciences’ MyoVista Insights™ Receives Epic Toolbox Designation for ECG Management System Category

GlobeNewswire
·
Mar 25

AIML Subsidiary NeuralCloud Taps Baker Institute for AI-Powered ECG Research Deal

TIPRANKS
·
Mar 25

Everus Construction Group amends 8-K to disclose Deloitte dismissal date as Feb. 25, 2026

Reuters
·
Mar 19

Milestone Pharmaceuticals to Present Data on CARDAMYST™ (etripamil) Nasal Spray at the 2026 American College of Cardiology Annual Scientific Session

GlobeNewswire
·
Mar 16

Cytokinetics Announces Four Presentations at the American College of Cardiology Annual Scientific Session & Expo

GlobeNewswire
·
Mar 16

Is It Too Late To Consider Everus Construction Group (ECG) After A 196% One-Year Surge?

Simply Wall St.
·
Mar 14

S&P 500 Futures Rise In Premarket Trading; AeroVironment, Campbell's Lag

Dow Jones
·
Mar 11

HeartBeam (NASDAQ: BEAT) Collaborates With Mount Sinai to Advance AI-ECG Algorithm Development

TIPRANKS
·
Mar 11

Strong 2025 Results and Acquisition Drive Might Change The Case For Investing In Everus Construction Group (ECG)

Simply Wall St.
·
Mar 10

HeartBeam: Commercial Partnership and FDA-Cleared ECG Platform Underpin Long-Term Growth and Buy Rating

TIPRANKS
·
Mar 05

Everus Construction Group Inc. Publishes Investor Presentation on Construction Services Platform and Growth Strategy

Reuters
·
Mar 03